DNA CONTENT AND THE PROLIFERATION MARKER KI-67 AS PROGNOSTIC INDICATORS IN RENAL-CELL CARCINOMA

被引：14

作者：

PAPADOPOULOS, I

WEICHERTJACOBSEN, K

SPRENGER, E

WACKER, HH

机构：

[1] Department of Urology, University of Kiel

[2] Institute of Cytopathology, University of Kiel

[3] Institute of Pathology, University of Kiel

来源：

UROLOGIA INTERNATIONALIS | 1994年 / 53卷 / 04期

关键词：

RENAL CELL CARCINOMA; DNA CONTENT; PROLIFERATION RATE (KI-67);

D O I：

10.1159/000282669

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Patients suffering from renal cell carcinoma have a generally poor prognosis. Even cases that are clinically in comparable stages can, however, take quite different courses. The basic prognostic factors, histological grade and TNM stage do not do justice to the heterogeneous biological behavior of this tumor entity. In this study, the possible prognostic indicators, DNA content and proliferation rate, assessed with Ki-67, were compared with the histological grade and the TNM stage. Though there was no correlation between the proliferation rate (Ki-67) and the two, there was a significant correlation between DNA content and both histological grade and TNM stage.

引用

页码：181 / 185

页数：5

共 50 条

[41] The prognostic value of Ki-67 expression in penile squamous cell carcinoma
Stankiewicz, Elzbieta
Ng, Mansum
Cuzick, Jack
Mesher, David
Watkin, Nick
Lam, Wayne
Corbishley, Cathy
Berney, Daniel M.
JOURNAL OF CLINICAL PATHOLOGY, 2012, 65 (06) : 534 - 537
[42] Ki-67 as a Prognostic Marker in Squamous Cell Carcinomas of the Vulva: A Systematic Review
Klamminger, Gilbert Georg
Eltze, Elke
Bitterlich, Annick
Degirmenci, Yaman
Hasenburg, Annette
Wagner, Mathias
Nigdelis, Meletios P.
JOURNAL OF CLINICAL MEDICINE, 2025, 14 (06)
[43] Prognostic relevance of the Ki-67 proliferation index in patients with mantle cell lymphoma
Jeong, Tae-Dong
Chi, Hyun-Sook
Kim, Min-Sun
Jang, Seongsoo
Park, Chan-Jeoung
Huh, Joo Ryung
BLOOD RESEARCH, 2016, 51 (02) : 127 - 132
[44] Ki-67 antisense therapy in murine renal cell carcinoma models
Kausch, I
Jiang, H
Brocks, C
Albers, A
Krüger, S
Sczakiel, G
Jocham, D
AKTUELLE UROLOGIE, 2005, 36 (02) : 142 - 148
[45] KI-67 Proliferation Index is a Better Prognostic Marker Than Mitotic Count in Neuroendocrine Tumors
Khan, Mohid S.
El-Khouly, Fatima
Toumpanakis, Christos
Meyer, Tim
Caplin, Martyn
Tu Vinh Luong
GASTROENTEROLOGY, 2011, 140 (05) : S116 - S116
[46] Evaluation of the proliferation marker Ki-67 and the IDH mutation in glioblastoma
Houssaini, Asmae Squalli
Lamrabet, Salma
Senhaji, Nadia
Sekal, Mohammed
Karkouri, Mehdi
Bennis, Sanae
EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 263 - 264
[47] Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort
Richardsen, Elin
Andersen, Sigve
Al-Saad, Samer
Rakaee, Mehrdad
Nordby, Yngve
Pedersen, Mona Irene
Ness, Nora
Grindstad, Thea
Movik, Ingeborg
Donnem, Tom
Bremnes, Roy
Busund, Lill-Tove
PLOS ONE, 2017, 12 (11):
[48] Physiological functions and roles in cancer of the proliferation marker Ki-67
Andres-Sanchez, Nuria
Fisher, Daniel
Krasinska, Liliana
JOURNAL OF CELL SCIENCE, 2022, 135 (11)
[49] Radiomic signatures of meningiomas using the Ki-67 proliferation index as a prognostic marker of clinical outcomes
Khanna, Omaditya
Kazerooni, Anahita Fathi
Arif, Sherjeel
Mahtabfar, Aria
Momin, Arbaz A.
Andrews, Carrie E.
Hafazalla, Karim
Baldassari, Michael P.
Velagapudi, Lohit
Garcia, Jose A.
Sako, Chiharu
Farrell, Christopher J.
Evans, James J.
Judy, Kevin D.
Andrews, David W.
Flanders, Adam E.
Shi, Wenyin
Davatzikos, Christos
NEUROSURGICAL FOCUS, 2023, 54 (06)
[50] Ki-67: More Hidden behind a 'Classic Proliferation Marker'
Gil, Raquel Sales
Vagnarelli, Paola
TRENDS IN BIOCHEMICAL SCIENCES, 2018, 43 (10) : 747 - 749

← 1 2 3 4 5 →